APA (7th ed.) Citation

L, P., G, G., F, N., M, M., A, P., D, I., . . . S, L. (2026). Second-line chemotherapy after gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer: Comparative outcomes and AI-guided treatment selection. The oncologist, 31(4), . https://doi.org/10.1093/oncolo/oyag085

Chicago Style (17th ed.) Citation

L, Procaccio, et al. "Second-line Chemotherapy After Gemcitabine Plus Nab-paclitaxel in Metastatic Pancreatic Cancer: Comparative Outcomes and AI-guided Treatment Selection." The Oncologist 31, no. 4 (2026). https://doi.org/10.1093/oncolo/oyag085.

MLA (9th ed.) Citation

L, Procaccio, et al. "Second-line Chemotherapy After Gemcitabine Plus Nab-paclitaxel in Metastatic Pancreatic Cancer: Comparative Outcomes and AI-guided Treatment Selection." The Oncologist, vol. 31, no. 4, 2026, https://doi.org/10.1093/oncolo/oyag085.